US 10442856
Methods of treating obesity with anti-ANGPTL8 antibodies
granted A61KA61K2039/505A61K39/3955
Quick answer
US patent 10442856 (Methods of treating obesity with anti-ANGPTL8 antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K39/3955, A61K45/06, A61P